Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Enhancing Cognitive and Work/School Outcomes in First Episode Psychosis Using Cognitive Self-Management Strategies

1 de agosto de 2026 actualizado por: Boston University Charles River Campus

Enhancing Cognitive and Work/School Outcomes in People With First Episode Psychosis: Testing the Effectiveness of Cognitive Self-Management Strategies

The goal of this pilot cluster randomized trial is to understand if adding a standardized cognitive self-management program, Thinking Skills for Work-Cognitive Self-Management Strategies (CSM) to Coordinated Specialty Care Supported Employment and Education (SEE) programs improves the work and school outcomes of young adults experiencing first episode psychosis. The main questions it aims to answer are:

  • Does adding the CSM program to usual SEE services lead to improved work and school outcomes, such as ability to find a job or enroll in school, or ability to keep a job or stay in school?
  • Does adding the CSM program to usual SEE services improve cognition and cognitive self-efficacy? Researchers will recruit six research sites and these will be randomized to either treatment as usual, where they will offer regular SEE services, or the experimental groups, where they will offer regular SEE services plus the CSM program.

Participants in both groups will be asked to complete a brief assessment at baseline, 6-months, 12-months, and 18-months. Participants in the experimental group will be asked to participate in the 12-session CSM program in addition to their regular SEE services.

Descripción general del estudio

Descripción detallada

The Coordinated Specialty Care (CSC) programs in the EPINET-TX Network provide Supported Employment and Education (SEE) services for young adults between the ages of 15-32 experiencing first episode psychosis (FEP). In this pilot cluster randomized clinical trial (RCT), six CSC programs representing different geographical regions including the urban southwest (serving a majority Latino population), the urban central and southeast (serving majority African American population), and the rural north and northeast (serving a racially/ethnically mixed population) that are part of the EPINET-TX Network will be recruited. Once the 6 SEE teams have been recruited, they will be randomized using a stratified procedure based on geographic region and populations served.

The 3 SEE teams randomized to the experimental group will be trained in CSM by the Boston University (BU) research team. During the training period, the CSC team program director and SEE specialist will be trained in CSM resources and methods, beginning with an online self-paced training course, followed by weekly and then biweekly zoom-based group supervision with BU researchers. CSM sessions will be audio-recorded as part of initial training and ongoing fidelity checks. Zoom meeting training sessions will also be recorded. CSM training is expected to take approximately three months, and the participating SEE programs will be reimbursed for staff training time. Designated site CSC personnel from both the experimental and the control group sites will be trained to administer the outcome assessments.

After training of CSC teams and assessors is complete, recruitment of young adults with FEP will begin at all 6 sites simultaneously. Recruitment of young adult participants will include information meetings conducted by the program directors of participating CSC programs, consent and assent meetings, and the baseline assessment. Once identified, these program directors will be added as staff on the Institutional Review Board (IRB).

The 6 CSC teams will then administer either the experimental intervention (CSM + SEE) intervention or the control intervention (SEE only). Staff within the experimental group will continue to receive support from the BU PI's, who will periodically administer the CSM Fidelity Scale to ensure CSM intervention fidelity.

Young adult participants in both the experimental and control groups will complete assessments at baseline, 6 months, 12 months, and 18 months. These assessments will take place in person by a trained onsite assessor. The baseline assessment battery will include a demographics questionnaire, history of employment and education questionnaire, the WRAT to assess reading level, and 2 cognitive assessments (described below). Follow-up assessments will only include the cognitive measures. These assessments are expected to take between 60-90 minutes for a total of 6 hours of time.

In addition, research sites will share the results of the Core Assessment Battery (CAB), an assessment that is administered as a part of routine CSC care every six months, with the BU researchers every 6 months. Additional information about prescribed medication, SEE program utilization, and psychiatric hospitalizations is normally collected quarterly and will be shared at each assessment. Education and employment logs will be collected weekly and shared with the BU research team. This information will be collected on all young adult participants.

Young adults with FEP in the experimental group will participate in the CSM intervention. The teaching of Cognitive Self-Management Strategies (CSM) by SEE specialists includes an additional 12 sessions that range from 45 to 60 minutes long. Thus, participants in the experimental group will complete about 18 hours of study activities over an 18-month period. Those in the control group will participate in the assessments, about 6 hours of study activities over an 18-month period.

After the study is over, participants from the control group still enrolled in the CSC program will be offered CSM if appropriate to their goals.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

60

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Susan R McGurk, PhD
  • Número de teléfono: 617-353-3549
  • Correo electrónico: mcgurk@bu.edu

Copia de seguridad de contactos de estudio

  • Nombre: Alexa Trolley-Hanson, MS
  • Número de teléfono: 617-353-3549
  • Correo electrónico: athanson@bu.edu

Ubicaciones de estudio

    • Texas
      • Big Spring, Texas, Estados Unidos, 79720
        • Reclutamiento
        • West Texas Centers Promoting Behavioral and Developmental Health
        • Contacto:
        • Investigador principal:
          • Amanda Ryan, PhD
      • Granbury, Texas, Estados Unidos, 76048
        • Reclutamiento
        • Pecan Valley Centers for Behavioral and Developmental Healthcare
        • Contacto:
        • Contacto:
        • Investigador principal:
          • Molly Lopez, PhD
      • Laredo, Texas, Estados Unidos, 78041
        • Reclutamiento
        • Border Region Behavioral Health Care
        • Contacto:
        • Investigador principal:
          • Molly Lopez, PhD
        • Contacto:
      • Longview, Texas, Estados Unidos, 75604
        • Aún no reclutando
        • Community Healthcore
        • Investigador principal:
          • Amanda Ryan, PhD
        • Investigador principal:
          • Molly Lopez, PhD
        • Contacto:

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Niño
  • Adulto

Acepta Voluntarios Saludables

No

Descripción

Inclusion Criteria:

  1. currently in their first 18 months of enrollment in the CSC program
  2. at least 15 years of age
  3. receiving SEE services but not employed or enrolled in school
  4. have the desire to work or resume school.

Exclusion Criteria:

1) Young adults who are not fluent in english

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: CSM plus SEE Group
The 3 sites (30 participants) from this site will receive the standardized 12 session CSM program in addition to regular SEE services. The CSM sessions will occur weekly and last between 45-60 minutes. They cover 12 different areas of cognition such as self-assessment, recognizing strengths, challenging negative thinking, attention and concentration, memory organization, planning ahead, problem-solving, and thinking speed.
CSM is a 12-session program that promotes the development of specific cognitive strategies to promote success in employment and education outcomes. This is a standardized, evidence-based intervention with adults with serious mental illness. Each session is facilitated by a trained cognitive specialist and lasts between 45- 60 minutes. Session topics include self-assessment of cognitive skills, recognizing strengths, challenging negative thoughts, attention and concentration, memory, organization, planning, and thinking ahead.
In this intervention, participants receive regular weekly Supported Education and Employment (SEE) services.
Comparador activo: Treatment as Usual
In this arm, the 3 sites (30 participants) will participate in regular weekly SEE services.
In this intervention, participants receive regular weekly Supported Education and Employment (SEE) services.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
School and Education Activity Tracker
Periodo de tiempo: Tracked weekly through study completion (about 18 months)
This qualitative measure tracks the participant's participation in education or employment activities on a weekly basis. It includes questions about the education or employment activity and the time spent completing the activity. The minimal value is 0, there is no maximum value.
Tracked weekly through study completion (about 18 months)
The Cognitive Problems and Strategies Assessment
Periodo de tiempo: Baseline, 6-, 12-, and 18-months
Standardized measure that assesses cognitive functioning and strategy use. It includes two subscales, the "Cognitive Problems Subscale" and the "Strategy Use Subscale", each consisting of 30 items that are scored from 0-3 (cumulative 0-90). A higher score on the Cognitive Problems Subscale indicates a worse outcome, whereas higher scores on the Strategy Use Subscale indicate better outcomes.
Baseline, 6-, 12-, and 18-months
Cognitive Self-Efficacy Scale
Periodo de tiempo: Baseline, 6-, 12-, and 18-months
Standardized measure that assesses an individual's confidence in everyday cognitive tasks. This is a 10 item scale with values ranging from 0 to 100, with higher values indicating better outcomes.
Baseline, 6-, 12-, and 18-months

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
The Clinical Outcomes in Measurement-based care Assessment of Symptoms and Severity (COMPASS-10)
Periodo de tiempo: baseline, 6-, 12-,18-months
This 10-item clinician-rated instrument evaluates positive, negative, and affective symptom severity for individuals experiencing early-phase or first-episode psychotic disorders. Rated on a scale from 0 (not present) to 6 (very severe). Lower values indicate treatment progress in this study.
baseline, 6-, 12-,18-months
The Global Functioning Social and Role Subscales
Periodo de tiempo: Baseline, 6-, 12-, 18-months
This 2 item scale measure was designed for young adults and measures a participant's social connections and daily responsibilities. This clinician-rated scale is scored from 1 to 10, where higher numbers indicate better outcomes.
Baseline, 6-, 12-, 18-months
The Personal Wellbeing Index
Periodo de tiempo: Baseline, 6-, 12-, and 18- months
This is a self-report, 8-item scale, that measures life satisfaction across standard of living, personal health, and relationships. Scores range from 0 (low-wellbeing) to 10 (high-wellbeing). Higher scores indicate better outcomes in this study.
Baseline, 6-, 12-, and 18- months
The Alcohol Use Scale
Periodo de tiempo: Baseline, 6-, 12-, and 18-months

This study uses 1 item from this scale, "Please rate your worst 1 month over the past 6 months."

Participants report the following ratings:

  1. Abstinent
  2. Use with Impairment
  3. Mild Alcohol Use
  4. Moderate Alcohol Use
  5. Severe Alcohol Use Lower scores indicate better outcomes.
Baseline, 6-, 12-, and 18-months
The Drug Use Scale
Periodo de tiempo: Baseline, 6-, 12-, and 18-months

This 1-item self-report scale measures a participant's drug use over the past 6 months. Participants report the following ratings:

  1. Abstinent
  2. Use with Impairment
  3. Mild Drug Use
  4. Moderate Drug Use
  5. Severe Drug Use Lower scores indicate better outcomes
Baseline, 6-, 12-, and 18-months
Substance Use Abuse Treatment Stage
Periodo de tiempo: Baseline, 6-, 12-, and 18-months

This 1 item scale measures the extent to which a participant is engaged in treatment for their substance use. It is a self-report scale in which the participant chooses one of the following options:

  1. pre-engagement, no contact with substance use treatment services
  2. engagement, limited contact with substance use treatment services
  3. early persuasion, regular contact but no change in use
  4. late persuasion, regular contact with reductions in use
  5. early active treatment, regular contact, reductions in use for 1 month
  6. late active treatment, regular contact, reductions in use and working towards abstinence
  7. relapse prevention=regular contact, achieved abstinence for 6 months, occasional relapses
  8. remission/recovery, no problems with substance use Higher scores indicate better outcomes
Baseline, 6-, 12-, and 18-months

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Demographics Form
Periodo de tiempo: Baseline only
Standardized set of questions about a participants age, gender, race/ethnicity, gender, and diagnosis
Baseline only
History of employment and education
Periodo de tiempo: Baseline only
Standardized set of questions about an individual's past employment and education activities
Baseline only

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Colaboradores

Investigadores

  • Investigador principal: Susan R McGurk, PhD, Boston University Center for Psychiatric Rehabilitation
  • Investigador principal: Kim Mueser, PhD, Boston University Center for Psychiatric Rehabilitation

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

10 de agosto de 2025

Finalización primaria (Estimado)

31 de enero de 2029

Finalización del estudio (Estimado)

31 de mayo de 2029

Fechas de registro del estudio

Enviado por primera vez

13 de mayo de 2026

Primero enviado que cumplió con los criterios de control de calidad

1 de agosto de 2026

Publicado por primera vez (Actual)

6 de agosto de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

6 de agosto de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

1 de agosto de 2026

Última verificación

1 de agosto de 2026

Más información

Términos relacionados con este estudio

Términos MeSH relevantes adicionales

Otros números de identificación del estudio

  • 7734E
  • 90RTEM0004 (Otro número de subvención/financiamiento: Nat. Institute on Disability Indep. Living and Rehab Research)

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

There are no plans to share IPD from this trial

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir